Yichang Humanwell Pharmaceutical is a finished-dose manufacturer based in China. It holds one active US drug master file across a filed portfolio of 2 molecules. Its filings concentrate with US FDA, DAV (Vietnam) and ARCSA (EC). Its GMP standing is certified by MFDS (Korea), TMDA (TZ) and ANVISA (Brazil).
| Site | FDA FEI |
|---|---|
| YICHANG, China | Not on file |
| China, China | 3004250049 |
| Hubei, Tanzania | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Remifentanil | SFDA (Saudi Arabia), US FDA | 2 |
| Hydromorphone | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | 22 | None |
| DAV (Vietnam) | 3 | None |
| ARCSA (EC) | 2 | None |
| EFDA (ET) | 1 | None |
| MINSA (CR) | 1 | None |
| Health Canada | 1 | None |
| MFDS (Korea) | None | 2 |
| TMDA (TZ) | None | 1 |
| ANVISA (Brazil) | None | 1 |
Choose your molecules and target markets. Yichang Humanwell Pharmaceutical comes back tiered against every other supplier able to file there.
Start for free